Annovis Bio, Inc. (ANVS) earnings
ANVS earnings moved a median of +1.12% by the close. Quarterly and annual ANVS reports and results, each read against the price at its own news timestamp. Back to the ANVS overview →
17 measured ANVS earnings events.
Where these ANVS earnings landedvs 16 measured ANVS earnings reactions
| Middle 50% of ANVS earnings reactions | -2.53% to +8.61% |
|---|---|
| Median reaction (to close) | +1.12% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 ANVS earnings events with a measured close landed between -2.53% and +8.61%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results | Press release | +0.00% | +1.09% | |
| Form 10-Q Annovis Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.49% | -4.92% | |
| Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results | Press release | +0.74% | +1.48% | |
| Form 10-Q Annovis Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.53% | -1.91% | |
| Form 10-K Annovis Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +4.53% | +11.42% | |
| Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results | Press release | +1.61% | +11.98% | |
| Form 10-Q Annovis Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.41% | — | |
| Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results | Press release | +6.74% | +1.12% | |
| Form 10-Q Annovis Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +6.74% | +1.12% | |
| Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results | Press release | -3.85% | -18.75% | |
| Form 10-Q Annovis Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.85% | -18.75% | |
| Form 10-K Annovis Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.01% | +6.32% | |
| Form 10-Q Annovis Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.88% | -4.38% | |
| Form 10-Q Annovis Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.24% | +7.93% | |
| Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results | Press release | +1.31% | +10.66% | |
| Form 10-Q Annovis Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.31% | +10.66% | |
| Form 10-K Annovis Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.00% | -0.33% |
Keep exploring
More ANVS: analyst actions → · SEC filings → · ANVS overview →